<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY accession="ERP118023" alias="ena-STUDY-UNIVERSITY OF MELBOURNE-23-10-2019-02:52:08:574-170" center_name="UNIVERSITY OF MELBOURNE">
    <IDENTIFIERS>
      <PRIMARY_ID>ERP118023</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject">PRJEB35032</EXTERNAL_ID>
      <SUBMITTER_ID namespace="UNIVERSITY OF MELBOURNE">ena-STUDY-UNIVERSITY OF MELBOURNE-23-10-2019-02:52:08:574-170</SUBMITTER_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Mining the methylome reveals extensive diversity in Staphylococcus epidermidis restriction modification</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Other"/>
      <STUDY_ABSTRACT>Staphylococcus epidermidis is a major cause of hospital-acquired infections, especially those related to implanted medical devices. Understanding how S. epidermidis causes disease and ways to combat these infections have been hindered by an inability to genetically manipulate the “hospital-adapted” strains that cause clinical disease. Here we provide the first comprehensive analyses of the mechanisms by which S. epidermidis resists the uptake of foreign DNA and demonstrate these to be distinct to those described for S. aureus, that until now had been assumed to be the same. Using these insights, we demonstrate an efficient approach for the genetic manipulation of S. epidermidis to enable the study of clinically relevant isolates for the first time.</STUDY_ABSTRACT>
      <STUDY_DESCRIPTION>Staphylococcus epidermidis is a major cause of hospital-acquired infections, especially those related to implanted medical devices. Understanding how S. epidermidis causes disease and ways to combat these infections have been hindered by an inability to genetically manipulate the “hospital-adapted” strains that cause clinical disease. Here we provide the first comprehensive analyses of the mechanisms by which S. epidermidis resists the uptake of foreign DNA and demonstrate these to be distinct to those described for S. aureus, that until now had been assumed to be the same. Using these insights, we demonstrate an efficient approach for the genetic manipulation of S. epidermidis to enable the study of clinically relevant isolates for the first time.</STUDY_DESCRIPTION>
    </DESCRIPTOR>
    <STUDY_ATTRIBUTES>
      <STUDY_ATTRIBUTE>
        <TAG>Bacteria</TAG>
        <VALUE>Organism</VALUE>
      </STUDY_ATTRIBUTE>
      <STUDY_ATTRIBUTE>
        <TAG>Methylome</TAG>
      </STUDY_ATTRIBUTE>
      <STUDY_ATTRIBUTE>
        <TAG>Staphylococcus</TAG>
        <VALUE>Genus</VALUE>
      </STUDY_ATTRIBUTE>
      <STUDY_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-11-21</VALUE>
      </STUDY_ATTRIBUTE>
      <STUDY_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2019-11-21</VALUE>
      </STUDY_ATTRIBUTE>
    </STUDY_ATTRIBUTES>
  </STUDY>
</STUDY_SET>
